Professional Compounding Centers of America (PCCA), 9901 South Wilcrest Drive, Houston, TX, 77099, USA,
Dermatol Ther (Heidelb). 2014 Dec;4(2):259-69. doi: 10.1007/s13555-014-0065-y. Epub 2014 Nov 20.
Wounding affects the integrity of the skin and can ultimately result in skin scarring. Current therapeutic goals of wound treatment focus on the reduction of scar formation and severity. However, scar formation itself varies not only between individuals based on factors such as ethnicity, but also within an individual based on the location of the wound. Therefore, the preparation of customized treatments for individual patients represents an important therapeutic goal in the fields of dermatology and wound healing. The objective of this study was to evaluate the usefulness of fatty acids found in pracaxi oil in a compounded topical anhydrous silicone base for wound and scar therapy.
Initially, 21 patients with various surgical, traumatic, or burn wounds and scars were enrolled into this case series. Patients applied a compounded topical anhydrous silicone base containing pracaxi oil with or without additional active ingredients, including pentoxifylline, caffeine, tranilast, and mupirocin. Wound/scar photographs taken before and after application of the compounded pracaxi oil topical formulation (with/without additional ingredients) were reviewed and adjudicated by a blinded dermatology reviewer. Improvements in wound size, coloration, and overall appearance before and after treatment were determined. Patient satisfaction was assessed after application of compounded topical formulation using a self-report questionnaire distributed at the time of dispensing.
A total of seven patients were considered available for analysis and were included in the study. In all seven cases, patients reported improvement in scar and wound attributes, including scar and wound size, severity, color, and pain associated with the scar or wound after application of the compounded medicine. On average, patients rated their satisfaction with treatment highly, with a mean score of 10 on a rating scale of 1-10. Retrospective review of wound/scar photographs demonstrated clinically relevant improvements in wound attributes as assessed by a dermatologist. Six of the seven wounds examined were considered "much improved" from baseline.
Application of a compounded anhydrous silicone base containing pracaxi oil alone or in combination with other active substances led to considerable improvements in wound healing and scar attributes and is a potentially useful option in the treatment of surgical, traumatic, or burn wounds and scars.
创伤会影响皮肤的完整性,最终导致皮肤瘢痕形成。目前的伤口治疗目标侧重于减少瘢痕形成和严重程度。然而,瘢痕形成本身不仅因个体的种族等因素而异,而且在个体内部也因伤口的位置而异。因此,为个别患者制定定制治疗方案是皮肤科和伤口愈合领域的一个重要治疗目标。本研究的目的是评估在复方无水硅酮基质中添加巴卡脂中发现的脂肪酸在伤口和瘢痕治疗中的有用性。
最初,将 21 名患有各种手术、创伤或烧伤伤口和瘢痕的患者纳入本病例系列研究。患者应用含有巴卡脂的复方无水硅酮基质,或添加其他活性成分,包括己酮可可碱、咖啡因、曲尼司特和莫匹罗星。应用复方巴卡脂局部制剂(含/不含其他成分)前后的伤口/瘢痕照片由一位盲法皮肤科评审员进行回顾和裁决。评估治疗前后伤口大小、颜色和整体外观的改善情况。在分发药物时,使用自我报告问卷评估患者在应用复方局部制剂后的满意度。
共有 7 名患者被认为可用于分析并纳入研究。在所有 7 例患者中,患者报告在应用复方药物后瘢痕和伤口特征得到改善,包括瘢痕和伤口大小、严重程度、颜色以及与瘢痕或伤口相关的疼痛。患者平均对治疗的满意度评价很高,评分量表得分为 1-10 时平均得分为 10。回顾性分析伤口/瘢痕照片显示,皮肤科医生评估的伤口特征有临床意义的改善。检查的 7 个伤口中有 6 个被认为从基线开始“明显改善”。
应用含有巴卡脂的复方无水硅酮基质单独或与其他活性物质联合应用可显著改善伤口愈合和瘢痕特征,是治疗手术、创伤或烧伤伤口和瘢痕的一种潜在有效选择。